Doctor explains what FDA'a approval of pancreatic cancer drug could mean for patients
The FDA has approved a drug that could extend the life of patients with late-stage pancreatic cancer.
CBS News' medical correspondent Dr.
Céline Gounder has more.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cbsnews.com — the content belongs to CBS News.